BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18836289)

  • 1. In vivo imaging of apoptosis.
    Blankenberg FG
    Cancer Biol Ther; 2008 Oct; 7(10):1525-32. PubMed ID: 18836289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging the molecular signatures of apoptosis and injury with radiolabeled annexin V.
    Blankenberg FG
    Proc Am Thorac Soc; 2009 Aug; 6(5):469-76. PubMed ID: 19687221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of labeled Annexin A5 in imaging of programmed cell death. From animal to clinical imaging.
    Kietselaer BL; Hofstra L; Dumont EA; Reutelingsperger CP; Heidendal GA
    Q J Nucl Med; 2003 Dec; 47(4):349-61. PubMed ID: 14973424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (99m)Tc-Annexin A5 quantification of apoptotic tumor response: a systematic review and meta-analysis of clinical imaging trials.
    Belhocine TZ; Blankenberg FG; Kartachova MS; Stitt LW; Vanderheyden JL; Hoebers FJ; Van de Wiele C
    Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):2083-97. PubMed ID: 26275392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo detection of apoptosis.
    Blankenberg FG
    J Nucl Med; 2008 Jun; 49 Suppl 2():81S-95S. PubMed ID: 18523067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging cell death in vivo.
    Blankenberg F; Mari C; Strauss HW
    Q J Nucl Med; 2003 Dec; 47(4):337-48. PubMed ID: 14973423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiolabeling of HYNIC-annexin V with technetium-99m for in vivo imaging of apoptosis.
    Blankenberg FG; Vanderheyden JL; Strauss HW; Tait JF
    Nat Protoc; 2006; 1(1):108-10. PubMed ID: 17406220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of treatment-induced apoptosis in oncology with PET and SPECT.
    Blankenberg FG
    Curr Pharm Des; 2008; 14(28):2974-82. PubMed ID: 18991713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Past, present, and future of annexin A5: from protein discovery to clinical applications.
    Boersma HH; Kietselaer BL; Stolk LM; Bennaghmouch A; Hofstra L; Narula J; Heidendal GA; Reutelingsperger CP
    J Nucl Med; 2005 Dec; 46(12):2035-50. PubMed ID: 16330568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting phosphatidylserine for radionuclide-based molecular imaging of apoptosis.
    Wuest M; Perreault A; Richter S; Knight JC; Wuest F
    Apoptosis; 2019 Apr; 24(3-4):221-244. PubMed ID: 30684144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translational imaging: imaging of apoptosis.
    Strauss HW; Blankenberg F; Vanderheyden JL; Tait J
    Handb Exp Pharmacol; 2008; (185 Pt 2):259-75. PubMed ID: 18626606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular imaging of apoptosis with radio-labeled Annexin A5 focused on the evaluation of tumor response to chemotherapy.
    Kuge Y; Zhao S; Takei T; Tamaki N
    Anticancer Agents Med Chem; 2009 Nov; 9(9):1003-11. PubMed ID: 19663783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiolabeled apoptosis imaging agents for early detection of response to therapy.
    Ogawa K; Aoki M
    ScientificWorldJournal; 2014; 2014():732603. PubMed ID: 25383382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time and again, children resemble their parents.
    Hicks RJ
    J Nucl Med; 2008 Oct; 49(10):1577-8. PubMed ID: 18794271
    [No Abstract]   [Full Text] [Related]  

  • 15. Imaging cyclophosphamide-induced intramedullary apoptosis in rats using 99mTc-radiolabeled annexin V.
    Blankenberg FG; Naumovski L; Tait JF; Post AM; Strauss HW
    J Nucl Med; 2001 Feb; 42(2):309-16. PubMed ID: 11216531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the imaging of programmed cell death.
    Blankenberg FG
    Curr Pharm Des; 2004; 10(13):1457-67. PubMed ID: 15134569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Imaging of Apoptosis in Ischemia Reperfusion Injury With Radiolabeled Duramycin Targeting Phosphatidylethanolamine: Effective Target Uptake and Reduced Nontarget Organ Radiation Burden.
    Kawai H; Chaudhry F; Shekhar A; Petrov A; Nakahara T; Tanimoto T; Kim D; Chen J; Lebeche D; Blankenberg FG; Pak KY; Kolodgie FD; Virmani R; Sengupta P; Narula N; Hajjar RJ; Strauss HW; Narula J
    JACC Cardiovasc Imaging; 2018 Dec; 11(12):1823-1833. PubMed ID: 29454770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved detection of cell death in vivo with annexin V radiolabeled by site-specific methods.
    Tait JF; Smith C; Levashova Z; Patel B; Blankenberg FG; Vanderheyden JL
    J Nucl Med; 2006 Sep; 47(9):1546-53. PubMed ID: 16954565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotracers for noninvasive molecular imaging of tumor cell death.
    Kapty J; Murray D; Mercer J
    Cancer Biother Radiopharm; 2010 Dec; 25(6):615-28. PubMed ID: 21204755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technetium-99m HYNIC-annexin V: a potential radiopharmaceutical for the in-vivo detection of apoptosis.
    Ohtsuki K; Akashi K; Aoka Y; Blankenberg FG; Kopiwoda S; Tait JF; Strauss HW
    Eur J Nucl Med; 1999 Oct; 26(10):1251-8. PubMed ID: 10541822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.